Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind crossover trial of inhaled AZD3199 vs formoterol vs placebo in asthma
2008-001724-32Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of AZD3199 in asthma (3 arms), sponsored by AstraZeneca. Primary endpoint: Pharmacodynamics of AZD3199 compared to placebo and formoterol. Started Apr 2008; status: completed.
02
Drugs
AZD3199
03
Conditions
asthma
Beyond the preview
Go deeper on 2008-001724-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001724-32.